Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3
- PMID: 9873005
- DOI: 10.1074/jbc.274.2.703
Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3
Abstract
An alternatively spliced variant of Smad2 with a deletion of exon 3 (Smad2Deltaexon3) is found in various cell types. Here, we studied the function of Smad2Deltaexon3 and compared it with those of wild-type Smad2 containing exon 3 (Smad2(wt)) and Smad3. When transcriptional activity was measured using the p3TP-lux construct, Smad2Deltaexon3 was more potent than Smad2(wt), and had activity similar to Smad3. Transcriptional activation of the activin-responsive element (ARE) of Mix.2 gene promoter by Smad2Deltaexon3 was also similar to that by Smad3, and slightly less potent than that by Smad2(wt). Phosphorylation by the activated transforming growth factor-beta type I receptor and heteromer formation with Smad4 occurred to similar extents in Smad2Deltaexon3, Smad2(wt), and Smad3. However, DNA binding to the activating protein-1 sites of p3TP-lux was observed in Smad2Deltaexon3 as well as in Smad3, but not in Smad2(wt). In contrast, Smad2(wt), Smad2Deltaexon3, and Smad3 efficiently formed ARE-binding complexes with Smad4 and FAST1, although Smad2(wt) did not directly bind to ARE. These results suggest that exon 3 of Smad2 interferes with the direct DNA binding of Smad2, and modifies the function of Smad2 in transcription of certain target genes.
Similar articles
-
Smad2Δexon3 and Smad3 have distinct properties in signal transmission leading to TGF-β-induced cell motility.J Biol Chem. 2023 Feb;299(2):102820. doi: 10.1016/j.jbc.2022.102820. Epub 2022 Dec 20. J Biol Chem. 2023. PMID: 36549646 Free PMC article.
-
The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.Kidney Int. 1999 Oct;56(4):1354-65. doi: 10.1046/j.1523-1755.1999.00680.x. Kidney Int. 1999. PMID: 10504488
-
Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.J Biol Chem. 1999 Oct 29;274(44):31229-35. doi: 10.1074/jbc.274.44.31229. J Biol Chem. 1999. PMID: 10531318
-
Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.Mol Cell Biol. 2000 Dec;20(23):9041-54. doi: 10.1128/MCB.20.23.9041-9054.2000. Mol Cell Biol. 2000. PMID: 11074002 Free PMC article.
-
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.EMBO J. 2000 Oct 2;19(19):5178-93. doi: 10.1093/emboj/19.19.5178. EMBO J. 2000. PMID: 11013220 Free PMC article.
Cited by
-
Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.J Biol Chem. 2013 Jun 21;288(25):18546-60. doi: 10.1074/jbc.M112.446591. Epub 2013 May 6. J Biol Chem. 2013. PMID: 23649632 Free PMC article.
-
Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.Mol Biol Cell. 1999 Nov;10(11):3801-13. doi: 10.1091/mbc.10.11.3801. Mol Biol Cell. 1999. PMID: 10564272 Free PMC article.
-
Essential role of Smad3 in angiotensin II-induced vascular fibrosis.Circ Res. 2006 Apr 28;98(8):1032-9. doi: 10.1161/01.RES.0000218782.52610.dc. Epub 2006 Mar 23. Circ Res. 2006. PMID: 16556868 Free PMC article.
-
Framework for a protein ontology.BMC Bioinformatics. 2007 Nov 27;8 Suppl 9(Suppl 9):S1. doi: 10.1186/1471-2105-8-S9-S1. BMC Bioinformatics. 2007. PMID: 18047702 Free PMC article.
-
TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.EMBO J. 2003 Sep 1;22(17):4465-77. doi: 10.1093/emboj/cdg428. EMBO J. 2003. PMID: 12941698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous